Matches in Nanopublications for { ?s ?p "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP615501.RAYcKBPnvSnSSVh8iwTWAb3XoodZkTuzPNeSR2TXMpeAg130_assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615501.RAYcKBPnvSnSSVh8iwTWAb3XoodZkTuzPNeSR2TXMpeAg130_provenance.
- NP349868.RAyhK263q20THwR-mkt40sHzsf_DHZaIEcxkS2E1SXlzc130_assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349868.RAyhK263q20THwR-mkt40sHzsf_DHZaIEcxkS2E1SXlzc130_provenance.
- assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP737475.RAjiNbrWvFkpDDDCMx6P054p5qaUrK4dubl2BqMZTxpmI130_assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP737475.RAjiNbrWvFkpDDDCMx6P054p5qaUrK4dubl2BqMZTxpmI130_provenance.
- NP1315606.RA2r7HzObmmNN4_7bDWy07EAhfpor5ng7twED0sa6WJCU130_assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1315606.RA2r7HzObmmNN4_7bDWy07EAhfpor5ng7twED0sa6WJCU130_provenance.
- NP1315607.RAzXp4L4cRwvvuTaTYkSPjk5Op1rLKiMAZJYazHk7c1o4130_assertion description "[Alteration in expression of MMP-9 or its inhibitor, the tissue inhibitor of metalloproteinase type 1 (TIMP-1), could increase degradation of extracellular matrix and lead to aneurysm formation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1315607.RAzXp4L4cRwvvuTaTYkSPjk5Op1rLKiMAZJYazHk7c1o4130_provenance.